ArticleUpdates in surgery2026
Application of three-dimensional visualization technology on one-step PTCSL for complex hepatolithiasis.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveThe one-step percutaneous transhepatic cholangioscopic lithotripsy (PTCSL) technology for the treatment of hepatolithiasis is still considered challenging. The aim of the present study was to evaluate the influence of three-dimensional (3D) visualization on one-step PTCSL , Perioperative and long-term clinical data were profoundly analyzed during the treatment of intrahepatic bile duct stones.
methodsWe reviewed data on 231 hepatolithiasis patients receiving surgical treatment in our department from January 2015 to January 2019, including 139 patients in group A treated with one-step PTCSL assisted by 3D visualization and 92 patients in group B treated with one-step PTCSL alone.
resultsThe short-term outcomes including hospital stay, intraoperative blood loss, immediate stone removal rate, and the long-term outcomes including postoperative complications and recurrence-free survival (RFS) were compared. The results showed that one-step PTCSL assisted by 3D visualization slightly reduced Intraoperative blood Loss (21.14 ± 17.91 ml vs. 21.47 ± 25.91 ml; P = 0.000) and hospital stay (12.21 ± 6.14 days vs. 18.77 ± 8.73 days; P = 0.000). Moreover, there are no significant differences in hospitalization expenses, stone final clearance rate and postoperative complications between the two groups.
conclusionThe 3D visualization can make one-step PTCSL a safe, effective, and promising treatment for patients with complicated primary hepatolithiasis. The perioperative and long-term outcomes are satisfactory for complicated primary hepatolithiasis.
Indexed as
Identifiers
42390783What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.